AIC
ORMP icon

AWM Investment Company’s Oramed Pharmaceuticals ORMP Stock Holding History

AWM Investment Company’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-409,316
Closed -$2.61M – 135
2015
Q1 		$2.61M Hold
409,316
– – 0.36% 80
2014
Q4 		$1.87M Buy
+409,316
New +$2.69M 0.25% 91

Other funds holding ORMP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

AWM Investment Company's ORMP Position: Q2 2015 in Review

AWM Investment Company sold out of Oramed Pharmaceuticals (ORMP) in Q2 2015, closing a stake of 409,316 shares — an estimated $2.61M sold.

AWM Investment Company first reported a position in ORMP in Q4 2014 and held it in 2 quarters. The position peaked at $2.61M in Q1 2015. 15 funds tracked by Wall St. Rank hold ORMP as of Q2 2015.

  • AWM Investment Company reported no remaining Oramed Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • AWM Investment Company sold 409,316 Oramed Pharmaceuticals shares in Q2 2015, an estimated $2.61M.
  • AWM Investment Company first reported a position in Oramed Pharmaceuticals in Q4 2014 and held it in 2 quarters.
  • AWM Investment Company's Oramed Pharmaceuticals position peaked at $2.61M in Q1 2015.
  • 15 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2015.

Based on AWM Investment Company's 13F filing for Q2 2015, filed 12 Aug 2015.